Dr. Neil Riordan, Founder of the Stem Cell Institute in Panama, sits down with Brad in his most in-depth podcast conversation since the Joe Rogan Experience. Together they unpack the data behind stem cell therapies, covering safety, efficacy, and the regulatory hurdles that continue to slow access in the United States.
TAKEAWAYS
Proven Safety, Untapped Potential Decades of global data show stem cell therapies can be safe and transformative — helping patients with conditions once thought untreatable. Yet in the U.S., that potential remains locked away from most patients.
Models for Reform Japan’s Regenerative Medicine Law and the UK’s business-first approach show what’s possible: frameworks that balance oversight with real-world access. Without reform, America risks falling behind in the future of medicine.
Outdated Regulatory Frameworks The FDA still relies on frameworks that haven’t been meaningfully modernized since the 1990s. These outdated rules treat stem cells like high-risk gene therapies, creating barriers that make approval near impossible for new therapies.